At IAFP 2026, ProGnosis Biotech highlighted the growing role of diagnostics in helping food safety professionals identify risks earlier, make confident decisions and strengthen control across their operations.
ProGnosis Biotech participated in IAFP 2026 in New Orleans, joining food safety professionals, researchers and industry experts in discussions around the evolving challenges shaping food production, quality control and risk management.
Across the event, one shift was clear: diagnostics are moving beyond their traditional role as a final checkpoint. Testing is no longer only about confirming whether a process has worked or identifying a problem after it has occurred. Its value increasingly lies in providing reliable information early enough to influence what happens next.
For laboratories, manufacturers and quality teams, that means greater visibility of potential risks, faster intervention and more control before an issue develops into a wider operational concern.
This perspective shaped ProGnosis Biotech’s presence at IAFP 2026. Through discussions on allergen control, hygiene verification, mycotoxin management and laboratory workflows, the company emphasized the importance of diagnostic solutions that combine scientific reliability with practical application in real food safety environments.
In this context, effective diagnostics are not simply about generating faster results. They are about making those results actionable, supporting stronger monitoring programs, guiding timely decisions and helping professionals respond with greater confidence.
Represented by Georgios Papageorgiou, Alan Deery, Gabriel Faubert, Paraskevas Makridis and Nikos Natsaridis, ProGnosis Biotech engaged directly with members of the international food safety community, exchanging perspectives on the challenges faced by laboratories, manufacturers and quality teams and exploring how diagnostic technologies can better respond to their evolving needs.
IAFP 2026 reinforced the growing connection between scientific progress and everyday food safety decision-making. As the industry moves towards more preventive and responsive approaches, diagnostics have an increasingly important role to play, not simply in detecting risk, but in helping professionals act before that risk escalates.
ProGnosis Biotech remains committed to advancing that role through practical diagnostic expertise, continued engagement with the food safety community and technologies designed to bring reliable information closer to the point of decision.
